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In this paper, we compared the birth weight distribution among 201 infant leukaemia (IL) cases with that of 440 noncancer controls
enrolled in Brazil in 1999–2005. Compared with the general population and the stratum 2500–2999g as reference, IL cases
weighing 3000–3999g presented an odds ratio (OR) of 1.68 (95% CI: 1.03–2.76), and those of 4000g or more, an OR of 2.28 (95%
CI: 1.08–4.75), Ptrendo0.01. Using hospital-based controls, the OR for 4000g or more, compared to 2500–2999g, was 1.30 (95%
CI: 1.02–1.43) after adjusting for confounders (gender, income, maternal age, pesticide and hormonal exposure during pregnancy).
The results suggest that high birth weight is associated with increased risk of IL.
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The positive association between birth weight and increased risk of
childhood leukaemia has been reported in industrialised countries
(Westergaard et al, 1997; Hjalgrim et al, 2003). Acute lympho-
blastic leukaemia (ALL) or acute myeloblastic leukaemia (AML)
affecting infants (under 12 months), which have been little studied,
often contain a chromosome break following the recombination of
the MLL gene with other genes (Felix and Lange, 1999). It has been
hypothesised that malignant clones, which will promote acute
leukaemias in early infancy would result from maternal exposures
to such environmental agents as dietary items and chemicals
inhibitors of DNA topoisomerase II activity (Ross et al, 1996b;
Alexander et al, 2001).
In a recent molecular case–control study in Brazil of infant
leukaemia (IL) with MLL gene rearrangements, a strong
and significant association between maternal use of hormones
during pregnancy and IL was observed (Pombo-de-Oliveira et al,
2006). Also of relevance, oestriol, progesterone and prolactin
measured during pregnancy are reported as positively associated
with birth weight and cancer risk in offspring (Mucci et al, 2003;
Nagata et al, 2006). We have therefore examined IL risk in relation
to birth weight using an existing database constructed by the
Brazilian Collaborative Study Group of Infant Acute Leukaemia
(BCSGIAL).
MATERIALS AND METHODS
The BCSGIAL is a cooperative study group in different states of
Brazil running a hospital-based case–control study to evaluate
associations with IL maternal exposures to environmental risk
factors during pregnancy. Details regarding case definition, control
selection, exclusion criteria and data collection have been
published previously (Emerenciano et al, 2006; Pombo-de-Oliveira
et al, 2006).
In this report, IL cases were included whenever birth weight data
were available. Controls were children, matched for age strata and
gender, with life-threatening conditions in the same hospitals as
the cases, excluding malignancy. Data on birth weight were
obtained from the health-care cards, regulated by the Brazilian
National Health System.
Birth weight data from IL cases were either compared with
hospital-based controls, or with population-based data relating to
all births in the general population of Brazil in the year 2000, and
consolidated by the Brazilian National Health System (Ministe ´rio
da Sau ´de, 2007). We ascertained birth weight by gender, leukaemia
type (ALL and AML) and MLL status. Crude and adjusted odds
ratios (ORs), and their 95% confidence intervals, were ascertained
for the birth weight strata (2500g or less; 2500–2999g; 3000–
3499g; 3500–3999g; and 4000g or more) adjusted for selected
confounders (gender, income, maternal age, hormonal intake and
pesticide exposure during pregnancy). The available national data
on birth weight merged 3000–3499g and 3500–3999g strata, and
this was followed with IL birth weight to allow the relevant
comparisons. Statistical analyses were performed using uncondi-
tional logistic regression models, as described elsewhere (Pombo-
de-Oliveira et al, 2006) and using the packages SSPS, version 13.5
(SPSS, Chicago, IL, USA). All collaborating institutions approved
the BCSGIAL Study, and written consent was obtained for
diagnostics procedures and for interviews with the mothers.
RESULTS
A total of 641 subjects, 201 cases (148 ALL and 53 AML) and 440
controls, stratified by age at diagnosis (0–12 versus 13–21
months), were enrolled in 1999–2005. The numbers of the main
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yclinical and laboratory data were same as described previously
(Emerenciano et al, 2006), but eight AML cases were excluded
due to lack of birth weight records. Eight cases, which were
misclassified in the previous report as biphenotypic leukaemia
with aberrant phenotype, were then categorized as ALL in the
present analysis.
Low birth weight (o2500g) was found in 16 (8.0%) cases and in
74 (16.8%) controls. The comparison between IL and controls
birth weight distributions showed that both ALL and AML weighed
on average 3488g at birth, compared with 3226g among controls
(P¼0.0002); median birth weights were 3310 and 3226g for ALL
and AML, respectively. Children with ALL had slightly higher birth
weights than AML, while male infants were slightly heavier than
female infants. The birth weight for male IL infants was 3349.2g
(s.d.¼49.6), with 95% CI: 3250.9–3447.5; for female IL infants, the
birth weight was 3262.8g (s.d.¼48.8), 95% CI: 3166.0–3359.7.
Further stratification by age revealed minimal differences between
the strata before or after 12 months of age at diagnosis of IL (data
not shown). It should, however, be remarked that MLL status in
the current study was unknown for a larger proportion of children
with low birth weight.
Data were stratified according to MLL gene status (positive,
negative and unknown). Mean birth weight in MLL
þve cases
(n¼68) was 3340g (s.d.¼64.85), while in MLL
 ve cases (n¼80),
it was 3310g (s.d.¼51.2); the medians were 3310 and 3300g,
respectively.
The magnitude of the association with birth weight IL was also
explored in increasing weight strata (Tables 1 and 2). Compared to
birth weights 2500–2999g, higher weights showed increased ORs
for either ALL or AML regardless of the control, population or
being hospital-based. Compared with the general population,
ALL cases weighing 3000–3999g showed an OR of 1.68 (95% CI:
1.03–2.76), and those weighing 4000g or more, an OR of 2.28(95%
CI: 1.08–4.75, Po0.01, Table 1). The cases that were MLL
þve
showed a higher birth weight than MLL
 ve cases at ages 12–21
months, and an inverse relationship in the first year of life was
observed (figures available online).
DISCUSSION
Despite the many studies on childhood leukaemia and birth
weight, few have focused on IL exclusively (Ross et al, 1997; Yeazel
et al, 1997), which is in spite of the value of risk factors specifying
the age group and the childhood leukaemia subtypes (Ma et al,
2005). The main strength of our study is probably the almost
complete ascertainment of IL in all Brazil except the North region,
Amazon.
In a population-based cohort, a positive linear relation was
reported between birth weight, and childhood ALL and AML
(Paltiel et al, 2004; Mclaughlin et al, 2006), more marked in AML
among infants (hazard ratio¼8.14, 95% CI: 1.8–38.9 at age 0–1
years), being particularly strong among female infants (P¼0.001)
(Paltiel et al, 2004). Among the variables included in this study,
including maternal origin, socioeconomic status, birth weight of
sibling higher than 3500g and family size, only birth weight
retained borderline significance (Paltiel et al, 2004). This associa-
tion has been explored in the present study using different
approaches, for IL ALL, AML and MLL status: according to a
single weight cut-point, and also exploring the magnitude of
association among subsequent birth weight strata. All approaches
yielded results that suggested an association between high birth
weight and IL.
In our study, low birth weight was more common among
controls (16.8%) than IL cases (8.0%), which may have estimates of
the magnitude of the association with birth weight (Figure 1).
Comparisons with the general population were therefore important
to control for bias in our hospital-based controls. In this
connection, three different OR estimates with birth weight were
obtained with the general population, providing unbiased esti-
mates but without adjusting confounders, crude ORs using
hospital controls and adjusted ORs using hospital controls.
Comparisons with the general population revealed an
insignificantly increased trend in ORs between ALL and birth
weight (Table 1) compared with children weighing 2500–2999g
at birth. Those weighing 3000–3999g showed an OR of 1.69
Table 1 Birth weight distribution, ALL, AML, MLL status (1999–2005) and all births in Brazil (general population), 2000
Birth weight General population
IL ALL AML MLL
+ve MLL
 ve
(in g) (all births) n OR (95% CI) n OR (95% CI) n OR (95% CI) n OR (95% CI) n OR (95% CI)
o2500 243835 16 1.52 (0.80–2.89) 11 1.50 (0.72–3.11) 5 1.59 (0.46–5.16) 6 1.56 (0.51–4.54) 3 0.61 (0.14–2.26)
2500–2999 696925 30 1.00 21 1.00 9 1.00 11 100 14 1.00
3000–3999 2036925 143 1.63 (1.08–2.47) 103 1.68 (1.03–2.76) 39 1.48 (0.64–3.28) 43 1.34 (0.67–2.75) 58 1.42 (0.77–2.66)
43999 189476 13 1.59 (0.79–3.17)
a 13 2.28 (1.08–4.75)
b 0 — 8 2.68 (0.99–7.15)
c 5 1.31 (0.41–3.89)
d
ALL¼acute lymphoblastic leukaemia; AML¼acute myeloblastic leukaemia; CI¼confidence interval; IL¼infant leukaemia; OR¼odds ratio.
aw
2 for trend¼4.60, P¼0.03.
bw
2
for trend¼6.66, Po0.01.
cw
2 for trend¼3.56, P¼0.059.
dw
2 for trend¼0.91, P¼0.34.
Table 2 Birth weight distribution by weight strata, IL and hospital-based controls, Brazil, 1999–2005
All IL ALL AML
Birth weight Hospital-based Crude Adjusted
a Crude Adjusted
a Crude Adjusted
a
(in g) controls n OR (95% CI) OR (95% CI) n OR (95% CI) OR (95% CI) n OR (95% CI) OR (95% CI)
o2500 74 16 0.87 (0.42–1.79) 0.88 (0.41–1.86) 11 0.86 (0.36–1.99) 0.99 (0.41–2.42) 5 0.91 (0.25–3.12) 0.74 (0.21–2.55)
2500–2999 121 30 1.00 1.00 21 1.00 1.00 9 1.00 1.00
3000–3499 150 81 2.18 (1.31–3.63) 1.23 (1.04–1.46) 57 2.19 (1.18–2.93) 1.24 (1.02–1.50) 24 2.15 (0.91–5.20) 1.20 (0.91–1.58)
3500–3999 72 62 3.47 (1.00–6.08) 1.29 (1.12–1.48) 46 3.68 (1.96–6.96) 1.30 (1.11–1.52) 15 2.80 (1.08–7.36) 1.23 (0.98–1.55)
b
43999 23 13 2.28 (0.96–5.37) 1.20 (1.02–1.43)
c 13 3.26 (1.32–8.01) 1.31 (1.09–1.57)
d —
ALL¼acute lymphoblastic leukaemia; AML¼acute myeloblastic leukaemia; CI¼confidence interval; IL¼infant leukaemia; OR¼odds ratio.
aAdjusted for sex, income, maternal
age, pesticide exposure and hormonal intake during pregnancy.
bw
2 for trend¼5.51, P¼0.018.
cw
2 for trend¼16.70, P¼0.00004.
dw
2 for trend¼18.14, P¼0.00002.
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y(95% CI: 1.03–2.76), and those born with 4000g or more, an OR
of 2.28 (95% CI: 1.08–4.75), suggesting a dose–response effect
(Po0.01). A quite similar trend with a borderline statistical
significance was also observed for MLL
þve cases (Table 1;
P¼0.059).
Birth weight strata of hospital controls suggested a dose–
response effect for IL, and also for ALL and AML subtypes after
adjusting for certain confounders. For AML, discordant results
have been reported with birth weight (Ross et al, 1997;
Westergaard et al, 1997; Yeazel et al, 1997; Hjalgrim et al, 2003).
Despite no AML infants weighed more than 4000g, suggestive
dose–response trend was indeed observed.
With respect to the biological mechanisms underlying birth
weight and IL development, one of the factor is hormone intake
during pregnancy to induce abortion to the index pregnancy (Ou
et al, 2002). In a previous report, we observed a high association
between hormone intake during pregnancy and IL with an OR of
8.76, 95% CI: 2.85–26.93 (Pombo-de-Oliveira et al, 2006). Women
used oral contraceptive pills in the belief that they caused
miscarriage, because abortion is illegal in Brazil. Although it could
be hypothesised that the association with birth weight was partly
due to such hormonal intake during the pregnancy, inducing an
increase in birth weight.
Although our results seem to point to an independent effect of
birth weight, it has been suggested that rather than birth weight per
se, the accelerated growth during pregnancy is the main process
leading to IL (Milne et al, 2007). On the other hand, the United
Kingdom Childhood Cancer Study has reported that babies who
developed leukaemia were heavier at birth (44000g, OR of 1.2,
95% CI: 1.0–1.4), as were their older siblings (44000g, OR of 1.4,
95% CI: 1.0–1.9) (Roman et al, 2005). Other mechanisms
suggested for the association with birth weight include the
supposition that IL is initiated by aberrant gene fusions, mainly
with MLL rearrangements (Ross et al, 1996a; Alexander et al,
2001). Interactions between high birth weight, prenatal oestrogen
exposure and leukaemia risks have also been suggested (Ross et al,
1996a; Baik et al, 2005; Ross, 2006).
An association has recently been reported between ALL and
birth weight among MLL
þve cases, but not among MLL
 ve ones
(Spector et al, 2007). In our study, a similar pattern was observed,
with a borderline linear trend suggestive of a causal relationship.
It has been suggested that insulin-like growth factor-1 (IGF-1)
promotes a proliferative advantage to damaged cells (Ross et al,
1996a; Ross, 2006). The link between birth weight, steroid
hormones in intrauterine life such as IGF-1 and cancer risk
indicates that such hormones tend to increase the number of stem
cells and, by extension, more proliferating immature cells are
exposed to harmful events, and consequently become more
susceptible to malignant transformation (Cavalieri et al, 1997;
Boyne et al, 2003). Whether enhanced cell proliferation and
genotoxic metabolites act jointly in an additive or synergistic
fashion, resulting in expansion of clonal cells with gene fusion
rearrangements, and clinical IL in high birth weight babies,
warrants further investigation in experimental models.
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